Lisdexamfetamine

BNF:: 4.4
Status:: Amber
Decision Date:: October 2013

Comments

See NHSE Shared Care Protocols for Adult ADHD services

2nd line drug choice

Amber Drug Classifications

1: Requiring specialist assessment to enable patient selection and initiation of treatment
3: Requiring short or medium term specialist monitoring of toxicity